Defibrillating the Data

This prospective validation study assessed the utility of the 60-minute HACOR score for identifying patients who will fail High Flow Nasal Cannula Oxygen (HFNO) therapy within the chaotic environment of the emergency department. The authors found that the score, calculated at the 60-minute mark, significantly outperformed the score derived upon admission in discriminating HFNO failure across an unselected ED population. Crucially, the study reports that the established threshold of a score greater than 5 remains the recommended cutoff for ruling out impending failure. They also noted an exploratory threshold of ≥ 8, but emphasized that this specific cutoff requires further prospective validation before clinical adoption.

This new ACP clinical policy synthesizes the literature to provide evidence-based guidance for managing adult patients presenting to the ED or ICU with major symptomatic bleeding while on direct oral anticoagulants (DOACs). The core question addressed is whether administering an agent-specific antidote offers a clinical advantage over standard reversal agents like prothrombin complex concentrate (PCC). The committee performed a systematic review to derive these recommendations, which is crucial given the increasing use of DOACs in acute care settings. The resulting policy directly informs the choice of reversal strategy in this high-stakes clinical scenario. It's a valuable resource for standardizing care pathways.

This new guide updates the approach to emergency thoracotomy, acknowledging how much practice has evolved since the seminal 2005 guidelines. It synthesizes current international recommendations with two decades of real-world operational experience, providing a modern, stepwise algorithm for both pre-hospital and emergency department settings. The authors emphasize that the procedure remains highly time-critical, necessitating clear procedural steps and troubleshooting advice for clinicians who may rarely perform it. Beyond just the technical steps, the guide incorporates crucial considerations regarding human factors and operational safety, which is key for maintaining high-stakes performance. Overall, it aims to support safer and more timely decision-making when this intervention is necessary in severe trauma.

This is the second installment of the ACEP Multidisciplinary Delphi Consensus Guidelines regarding unscheduled procedural sedation, and it's crucial to remember that these are official practice policies, not peer-reviewed research. The article synthesizes expert consensus to provide actionable clinical guidelines for managing sedation outside of a controlled setting. It outlines best practices for various aspects of procedural sedation, which is highly relevant for daily emergency department practice. Because these guidelines represent a consensus effort, they are designed to provide a unified standard of care across different clinical scenarios. Given the importance of procedural sedation safety, reviewing these established policies is a valuable use of time.

This recent publication addresses the ongoing debate surrounding the use of Type O whole blood for prehospital resuscitation in trauma and hemorrhage. The authors present data regarding the utility of administering whole blood products outside of the hospital setting. The core of the discussion revolves around whether whole blood offers a distinct advantage over current standard resuscitation practices in the field. It is important to note that this is a discussion of prehospital management, which inherently presents logistical and practical challenges compared to the controlled environment of the trauma bay. The findings contribute to the evolving guidelines for massive transfusion protocols in austere or remote trauma settings.

This randomized controlled trial directly addresses the management of severe acute pain following hip fractures in older adults presenting to the emergency department, comparing an ultrasound-guided pericapsular nerve group (PENG) block against standard intravenous morphine. The study found that the PENG block conferred a significantly greater median reduction in pain scores at 30 minutes compared to the morphine group, and critically, no patients in the block group required rescue analgesia, whereas nearly 6% of the morphine group did. Furthermore, the analysis suggested the PENG block provided a more sustained reduction in pain over time. Overall, the authors conclude that the PENG block represents a highly effective and safe alternative to IV opioids for this specific, high-acuity population.

This is the first installment of the ACEP Delphi Consensus Guidelines addressing unscheduled procedural sedation, which is a critical area for emergency department practice. The guidelines establish foundational principles, necessary oversight mechanisms, and frameworks for quality monitoring when sedation is administered outside of a controlled setting. It's important to remember that these are official ACEP policy statements, meaning they represent consensus guidelines rather than findings from a standard peer-reviewed research article. The document provides a structured approach to standardizing care, which is invaluable for departmental policy development. Pay close attention to the sections detailing who should be involved in the decision-making process and how quality metrics should be tracked to ensure patient safety.

The ORIENTAL-MeVO trial provides an update on endovascular thrombectomy for medium-vessel occlusion strokes, an area where evidence has historically been somewhat mixed despite these occlusions representing a significant proportion of ischemic strokes. This open-label, blinded-outcome randomized controlled trial enrolled adults with moderate-to-severe deficits (NIHSS ≥ 6) presenting within 24 hours. The study compared thrombectomy combined with standard medical care against medical management alone, focusing on functional independence at 90 days. The results showed a numerically higher rate of functional independence in the group receiving thrombectomy (58.6%) compared to the control group (46.6%). Overall, this data suggests a potential benefit, though the authors note the need for careful interpretation given the existing variability in the literature.

This literature review directly compared the utility of intranasal versus intramuscular epinephrine for managing anaphylaxis symptoms. The authors synthesized data from numerous publications to assess whether intranasal administration offers comparable efficacy to the established intramuscular route. The review noted that the evidence base was somewhat heterogeneous, drawing from case series and abstracts, which naturally raises questions about the robustness of the findings. Ultimately, the authors concluded that current evidence is insufficient to definitively state that intranasal epinephrine matches the efficacy of IM epinephrine. Therefore, the consensus remains that IM epinephrine is the standard of care for rapid symptom control in anaphylaxis.

This consensus statement offers updated, practical recommendations specifically for prehospital care providers managing suspected crush injury in the UK, aiming to reduce morbidity and mortality. A key point of discussion is the shift away from previous aggressive management protocols, particularly concerning fluid resuscitation and the emphasis placed on hyperkalemia monitoring. The authors structured these guidelines following a comprehensive evidence review and consensus process, acknowledging that the context of prehospital care dictates some of the differences from prior advice. While tailored for the UK setting, the core principles discussed regarding initial management are likely relevant to other developed healthcare systems. Overall, it provides a structured, actionable framework for field teams.

This alert addresses a potential complication associated with the SPEAR device, a novel 10-gauge catheter-over-needle system marketed for blind, out-of-hospital needle decompression for suspected pneumothorax. The device is designed for anterior or lateral placement in patients where pneumothorax is suspected but not confirmed. A key procedural detail highlighted is the recommendation within the instructional materials to insert the device approximately 3 cm to contact a rib before advancing the catheter into the thoracic cavity. Given that this is a new device used in a blind fashion outside of a controlled setting, the authors are flagging this for the attention of emergency physicians, trauma specialists, and EMS directors to ensure awareness of potential risks.

This review discusses the premature halt of the PECARN STArT trial, which was investigating the use of intravenous arginine for managing acute pain episodes in sickle cell disease patients. The most striking finding isn't about the drug itself, but rather the enormous variability in clinical outcomes, noting that the median time to crisis resolution differed by as much as 61 hours across the participating hospitals. This suggests that institutional protocols and local practices play a much larger role in patient management than the intervention being tested. The authors emphasize that the variability points toward actionable, site-specific improvements rather than a single pharmaceutical solution. They highlight that optimizing immediate care measures, such as early analgesia administration, might be more impactful than the drug under study.

This prospective study examined the relationship between the timing of norepinephrine initiation and 28-day all-cause mortality in a cohort of 138 septic patients. The authors used Cox regression analysis to compare parameters between survivors and non-survivors, finding a significant association between the time to norepinephrine (NE time) and overall mortality. Notably, the analysis demonstrated that initiating NE therapy within the first 60 minutes following the onset of hypotension was associated with a reduced risk of death. Furthermore, the non-survivor group exhibited a substantially longer median NE time compared to the survivor group, suggesting a temporal component to adverse outcomes in sepsis management.

I dive deep into member-submitted airway nightmares, breaking down how to manage petrified "airway concrete" and high-risk hypoxemia. Learn how to apply the CHOP criteria, avoid physiological arrest during induction in cardiogenic shock, and handle extreme metabolic acidosis. EMCrit Project by Scott Weingart, MD FCCM .

This current issue of the Emergency Medicine Journal dedicates attention to optimizing analgesic strategies, with a particular focus on managing severe pain, exemplified by hip fractures. The featured Editor's Choice randomized trial directly compared pericapsular nerve group (PENG) blocks against standard intravenous morphine administration in this setting. The results suggest a favorable profile for PENG blocks, indicating they are not only safer but also provide analgesia that is both earlier in onset and more sustained compared to the opioid regimen. This reinforces the general principle that regional anesthesia remains a cornerstone for opioid-sparing analgesia in the emergency department. It's a good reminder that comprehensive emergency care encompasses not just the patient, but also the resources and practices supporting the entire clinical team.

This review discusses the AUGMENT-VA randomized controlled trial, which investigated the utility of manual pressure augmentation (MPA) applied during defibrillation for out-of-hospital cardiac arrest. The authors highlight that while MPA was shown to significantly decrease transthoracic impedance, a key physiological marker, this improvement did not correlate with any benefit in the primary clinical endpoints, specifically survival to hospital discharge, when compared to standard defibrillation protocols. This suggests a potential disconnect between improving a measurable physiological parameter and achieving actual improved patient outcomes in the field. It serves as a good reminder that optimizing one measurable aspect of resuscitation does not automatically translate to better overall survival.

This article strongly argues for the increased emphasis on common femoral artery (CFA) cannulation and sheath insertion within emergency medicine training programs. The authors point to the growing reliance on endovascular resuscitation techniques, such as those used in ECMO and ECPR, and the persistent need for central arterial pressure monitoring in critically ill patients as the primary drivers for this focus. While standard arterial line placement is already considered core training, the specific skill of achieving reliable CFA access for advanced procedures is currently underemphasized in the field. Given the rising global rates of ECPR and the anticipated simplification of ECMO management, mastering this technical skill is becoming paramount for emergency physicians.

This response addresses a letter to the editor concerning the relationship between triage accuracy and the timeliness of care in the emergency department. Analyzing a massive dataset of over 5.3 million ED encounters across 21 community sites, the authors reiterate a significant finding: a substantial portion of the sickest patients are being undertriaged. More critically, they demonstrate a tangible consequence of this undertriage, showing that these critically ill patients experience a measurable delay in receiving care, specifically a median delay of 8 minutes when compared to their correctly triaged, high-acuity counterparts. This underscores that triage performance isn't just an abstract quality metric; it has direct, quantifiable impacts on patient throughput and immediate clinical management.

The recent PECARN PRoMPT BOLUS trial directly addressed the common dilemma of fluid choice in pediatric patients with suspected septic shock, comparing normal saline against balanced crystalloids for initial resuscitation. The primary takeaway from this trial is that, regarding major endpoints like mortality and kidney injury, there was no discernible difference between administering either normal saline or balanced crystalloids. This suggests that, at least for initial resuscitation in this specific cohort, the choice between these two common crystalloids may not significantly impact patient outcomes. It's a valuable piece of data because it helps de-escalate the perceived need for a specific fluid type, offering clinical flexibility.

This issue compiles highlighted research abstracts from several international emergency medicine societies, providing a broad overview of current literature. One notable abstract details a randomized, double-blinded, double-dummy prospective trial comparing intranasal versus subcutaneous ketamine for managing acute pain following musculoskeletal trauma in the emergency department. The study design suggests a rigorous comparison of two common analgesic routes for this common clinical scenario. While the full results are not provided here, the inclusion of this trial highlights ongoing efforts to optimize multimodal analgesia in the trauma setting. Reviewing these abstracts is a good way to stay current with diverse international research findings.